Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion.
about
RNA-Based Vaccines in Cancer ImmunotherapyRecombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyondTherapeutic cancer vaccines: past, present, and futureThe immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapyTrends in cancer immunotherapyDendritic cell-based vaccines: barriers and opportunitiesRNA as performance-enhancers for dendritic cells.The evolving role of dendritic cells in cancer therapy.Engineering dendritic cells to enhance cancer immunotherapy.mRNA transcript therapy.Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune ResponseAdenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12.Design and Facile Synthesis of New Dinucleotide Cap Analog Containing Both 2' and 3'-OH Modification on M⁷Guanosine Moiety.Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo.Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS.Latest development on RNA-based drugs and vaccines.
P2860
Q26776028-BD03C571-E7FF-4236-BC3C-3EFD240ABFBCQ26861563-E31601D3-2142-4111-A785-654FFC6ACA58Q26863283-E09EFA62-8591-4ED9-9D74-449C5C700134Q33466002-F9AC4647-3888-400E-8171-F48DA4183690Q33637584-FE7AB09D-2263-4C20-A3F4-9A32FC38AC32Q34052702-314879B9-D554-4006-AD04-9F26467A717BQ34661797-84B7BFD9-C6F6-4EC2-851E-7E4BBFC8B424Q37686532-3998D7A4-8030-48D2-8002-9F73027EDF82Q37687418-6AE8A84C-C264-4FDE-9E6C-1FB7413EA2ACQ37862064-A193826E-03DB-4C19-9A7F-F7A0CF7560C7Q38264088-14FFE47C-74F5-4E77-9108-A3901E26A824Q39791507-A3B28EE6-21FF-41FE-B9BB-36ED7C179824Q40437659-24EB436A-9B0F-44C5-B476-13305AB0EF21Q40648279-0BE82AA8-C82B-46F8-82B1-01DEADB692DFQ45858586-A1215D11-D36A-47F4-9238-6CC7BFB31E69Q52868672-9383A9C4-78B7-4BDB-951D-98339B452B8FQ55231576-F73537FB-26A3-482E-8DDA-C0C3AAC16BAA
P2860
Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Ectopic expression of a trunca ...... igh levels of IL-12 secretion.
@ast
Ectopic expression of a trunca ...... igh levels of IL-12 secretion.
@en
type
label
Ectopic expression of a trunca ...... igh levels of IL-12 secretion.
@ast
Ectopic expression of a trunca ...... igh levels of IL-12 secretion.
@en
prefLabel
Ectopic expression of a trunca ...... igh levels of IL-12 secretion.
@ast
Ectopic expression of a trunca ...... igh levels of IL-12 secretion.
@en
P2093
P2860
P356
P1476
Ectopic expression of a trunca ...... igh levels of IL-12 secretion.
@en
P2093
Atsushi Hinohara
Charles A Nicolette
David Calderhead
Don Healey
Irina Y Tcherepanova
Joe Horvatinovich
Melissa D Adams
Xiaorong Feng
P2860
P2888
P356
10.1186/1471-2199-9-90
P577
2008-10-17T00:00:00Z
P5875
P6179
1016142700